Beranda › Dermatitis Atopik (Eksim) › Alabama › Birmingham
Uji klinis Dermatitis Atopik (Eksim) di Birmingham, AL
9 studi untuk Dermatitis Atopik (Eksim) mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Menerima pesertaStudi observasional
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Menerima pesertaFase 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- Enveda Investigative Site, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Menerima pesertaFase 1Sukarelawan sehat diterima
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Menerima pesertaFase 3
- Cahaba Dermatology & Skin Health Center, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Menerima pesertaFase 3
- Leo Pharma Investigational site, Birmingham
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Menerima pesertaFase 3
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Menerima pesertaFase 2
- Allervie Clinical Research, Birmingham
Uji klinis Dermatitis Atopik (Eksim) di kota lain
- New York City, NY13 studi
- Washington, DC11 studi
- Los Angeles, CA11 studi
- San Diego, CA10 studi
- San Antonio, TX10 studi
- Miami, FL9 studi
- Troy, MI8 studi
- Huntington Beach, CA8 studi
- Dallas, TX8 studi
- Sacramento, CA8 studi
- Tampa, FL7 studi
- Indianapolis, IN7 studi
Studi lain di Birmingham
- Kanker (semua jenis)30 studi
- Kanker Payudara24 studi
- Obesitas23 studi
- Kanker Ovarium23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Leukemia Mieloid Akut21 studi
- Mieloma Multipel18 studi
- PPOK17 studi
- Penyakit Kardiovaskular17 studi
- Kelebihan Berat Badan16 studi
- Kanker Endometrium16 studi
- Diabetes Tipe 216 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.